News

Podimetrics Expands Leadership Team with Addition of Chief Commercial Officer, Barbara Greising

Podimetrics, creator of the SmartMat™ and integrated clinical and patient support services that can help save the limbs and lives of people living with complex diabetes, today announced Barbara Greising will be joining the Podimetrics executive leadership team as Chief Commercial Officer. She will be tasked with ensuring more people — particularly those most at […]

Podimetrics Expands Leadership Team with Addition of Chief Commercial Officer, Barbara Greising Read More »

IDE Study Data Demonstrates Shorter Length of Stay and Recovery Time for Patients Treated with Limiflex™ Dynamic Sagittal Tether™ (DST) Stabilization

Decompression Surgery with DST Stabilization May Be Viable Alternative to Transforaminal Lumbar Interbody Fusion (TLIF) for Degenerative Spondylolisthesis  San Carlos, Calif. (June 1, 2023) – A recently published paper in The Open Orthopaedics Journal compared outcomes for degenerative spondylolisthesis surgery using decompression and Empirical Spine’s LimiFlex™ Dynamic Sagittal Tether™ (DST) stabilization versus transforaminal lumbar interbody

IDE Study Data Demonstrates Shorter Length of Stay and Recovery Time for Patients Treated with Limiflex™ Dynamic Sagittal Tether™ (DST) Stabilization Read More »

Mindera Health™ Announces Change to Executive Leadership Team

Ron Rocca to Become Chief Executive Officer SAN DIEGO, CA – May 11, 2023 – Mindera Health™, the developer of Mind.Px™, the first realization of precision medicine in psoriasis, has announced a change in its executive leadership team. The company has announced industry veteran Ron Rocca will succeed George Mahaffey as President and Chief Executive

Mindera Health™ Announces Change to Executive Leadership Team Read More »

Mindera Health™ Announces Coverage with Evidence Project with Highmark, Inc. to Advance Moderate-to-Severe Psoriasis Patient Care and Reduce Specialty Drug Spending

Mindera Health™ Announces Coverage with Evidence Project with Highmark, Inc. to Advance Moderate-to-Severe Psoriasis Patient Care and Reduce Specialty Drug Spending Project will evaluate Mind.Px’s™ impact on physician “trial and error” prescribing behavior and overall net savings by prescribing the correct biologic class the first time SAN DIEGO, CA – April 11, 2023 – Mindera

Mindera Health™ Announces Coverage with Evidence Project with Highmark, Inc. to Advance Moderate-to-Severe Psoriasis Patient Care and Reduce Specialty Drug Spending Read More »

Aortix™ Pump Therapy Leads to Rapid Decongestion and Improved Kidney Function in Hospitalized Patients with Heart Failure and Worsening Renal Function

HOUSTON, TX – MARCH 21, 2023 – Procyrion, Inc., a medical device company dedicated to improving outcomes for patients with cardiac and renal impairment, announced today that use of its Aortix™ percutaneous mechanical circulatory support (pMCS) device led to rapid decongestion in a pilot study of patients admitted to the hospital with acute decompensated heart

Aortix™ Pump Therapy Leads to Rapid Decongestion and Improved Kidney Function in Hospitalized Patients with Heart Failure and Worsening Renal Function Read More »

Mindera Health™ Appoints Linh H. Le as Chief Financial Officer and Chief Operating Officer

Mindera Health™ Appoints Linh H. Le as Chief Financial Officer and Chief Operating Officer Industry Veteran will assist in commercialization of Mind.PxTM to implement precision medicine for biologic treatment of moderate-to-severe psoriasis SAN DIEGO, CA – March 14, 2023 – Mindera Health, the developer of Mind.Px™, the first realization of precision medicine in psoriasis, has

Mindera Health™ Appoints Linh H. Le as Chief Financial Officer and Chief Operating Officer Read More »

Koya Medical Selected for Poster Presentation of the NILE Clinical Trial, awarded Gold medal at AMCP 2023

OAKLAND, Calif., Mar. 13, 2023 Koya Medical, a healthcare company on a mission to transform venous and lymphatic care through innovative, people-centric solutions, today announced their selection for a poster presentation of the NILE Trial at the upcoming Academy of Managed Care Pharmacy (AMCP) conference being held March 21-24, 2023, in San Antonio, Texas. The

Koya Medical Selected for Poster Presentation of the NILE Clinical Trial, awarded Gold medal at AMCP 2023 Read More »

Procyrion Announces Successful First-in-Human Cases with Aortix™ Pump to Prevent Acute Kidney Injury in Patients Undergoing Cardiac Surgery

HOUSTON, TX – FEBRUARY 22, 2023 – Procyrion, Inc., a medical device company dedicated to improving outcomes for patients with cardiac and renal impairment, announced today successful treatment of the first patients in the A PRIORI (Aortix therapy for Perioperative ReductIon Of Renal Injury) pilot trial to evaluate the performance of its Aortix™ percutaneous mechanical

Procyrion Announces Successful First-in-Human Cases with Aortix™ Pump to Prevent Acute Kidney Injury in Patients Undergoing Cardiac Surgery Read More »

Thoraguard Intelligent Chest Tube Management System Reduces Hospital Stay; Preferred by Healthcare Providers –

New Peer-Reviewed Clinical Study Demonstrates Thoraguard® Advantages Over Conventional Analog Systems Following Lung Surgery OMAHA, Ne., September 13, 2022—Centese, Inc. announces the results of a newly published peer-reviewed clinical study on its Thoraguard Intelligent Chest Tube Management System for use following lung surgery. The study published in the Journal of Thoracic Disease by the thoracic

Thoraguard Intelligent Chest Tube Management System Reduces Hospital Stay; Preferred by Healthcare Providers – Read More »

Study validates the first automated chest tube clearance system for cardiac surgery –

Peer-reviewed clinical study shows Thoraguard® delivers effective, automated chest tube drainage following cardiac surgery Omaha, NE, July 26, 2022 — Centese, Inc. announces the first peer-reviewed clinical study on its Thoraguard® digital drainage system for cardiac surgery at Stanford University Medical Center, published in the Journal of Thoracic and Cardiovascular Surgery Open. Thoraguard is the

Study validates the first automated chest tube clearance system for cardiac surgery – Read More »